Primary record
Carbamic acid, N-(4-((1-((3-fluorophenyl)methyl)-1H-indazol-5-yl)amino)-5-methylpyrrolo(2,1-F)(1,2,4)triazin-6-yl)-, (3S)-3-morpholinylmethyl ester
- 库存
- 3,105 克
- 纯度
- 98.9 %
- CAS
- 714971-09-2
化合物标识与属性
- CAS
- 714971-09-2
- PubChem CID
- 10437018
- SMILES
- CC1=C2C(=NC=NN2C=C1NC(=O)OC[C@@H]3COCCN3)NC4=CC5=C(C=C4)N(N=C5)CC6=CC(=CC=C6)F
- Canonical SMILES
- Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12
名称与同义词
- BMS-599626
- 714971-09-2
- AC480
- AC-480
- BMS 599626
- AC480 (BMS-599626)
- AC1480 (free base)
- BMS599626
- RefChem:120731
- MFCD10565678
- D0U4FF
- CHEMBL1645462
- C27H27FN8O3
- cc-393
- DTXSID60221714
- GTPL7647
- orb1701670
- UNII-2252724U5N
- SCHEMBL12065349
- SCHEMBL29356969
- CTK8B6780
- (S)-Morpholin-3-ylmethyl (4-((1-(3-fluorobenzyl)-1H-indazol-5-yl)amino)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl)carbamate
- AOB5594
- DTXCID90144205
- SYN1142
- GLXC-06683
- EX-A2296
- KS-000008GE
- PDB97109
- ZINC6717782
- AC 480
- ANW-54337
- BDBM50333373
- C27H44O11
- NSC764135
- NSC799323
- s1056
- 2252724U5N
- BMS 599626 [WHO-DD]
- AKOS015999853
- BCP9000428
- CCG-269915
- CS-0407
- DB12318
- NSC-764135
- NSC-799323
- RL05125
- SDCCGSBI-0654332.P001
- CID10437018
- PAN-HER KINASE INHIBITOR AC480
- NCGC00346483-01
- NCGC00346483-05
- NCGC00346483-11
- NCGC00346483-12
- AC-32830
- AS-16281
- CID 10437018
- CID:10437018
- HY-10251
- BMS-599626 (AC480)
- SID:505117515
- TC-143082
- A2822
- B5520
- BMS-599626 (AC480)?
- NS00070341
- X7467
- Y0348
- J3.049.529B
- Q-4495
- BMS-599626, >=98% (HPLC)
- A857845
- C545531
- BRD-K07106112-003-03-8
- BRD-K07106112-300-01-2
- Q27075357
- Carbamic acid, N-(4-((1-((3-fluorophenyl)methyl)-1H-indazol-5-yl)amino)-5-methylpyrrolo(2,1-F)(1,2,4)triazin-6-yl)-, (3S)-3-morpholinylmethyl ester
- B0084-259278
- (S)-morpholin-3-ylmethyl 4-(1-(3-fluorobenzyl)-1H-indazol-5-ylamino)-5-methylpyrrolo[1,2-f][1,2,4]triazin-6-ylcarbamate
- [(3S)-morpholin-3-yl]methyl N-[4-[[1-[(3-fluorophenyl)methyl]indazol-5-yl]amino]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]carbamate
- 1,2,3,4-Tetra-O-pivaloyl-??-D-glucopyranuronic acid methyl ester
- [(3S)-Morpholin-3-yl]methyl N-[4-[[1-[(3-fluorophenyl)methyl]indazol-5-yl]amino]-5-methyl-pyrrolo[2,1-f][1,2,4]triazin-6-yl]carbamate
- 873837-23-1
- ((3S)-morpholin-3-yl)methyl N-(4-((1-((3-fluorophenyl)methyl)-1H-indazol-5-yl)amino)-5-methylpyrrolo(2,1-f)(1,2,4)triazin-6-yl)carbamate
- ((3S)-morpholin-3-yl)methyl N-(4-((1-((3-fluorophenyl)methyl)indazol-5-yl)amino)-5-methylpyrrolo(2,1-f)(1,2,4)triazin-6-yl)carbamate
- (3S)-3-Morpholinylmethyl-[4-[[1-[(3-fluorophenyl)methyl]-1H-indazol-5-yl]amino]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]-Carbamic acid
- (3S)-MORPHOLIN-3-YLMETHYL N-[4-({1-[(3-FLUOROPHENYL)METHYL]INDAZOL-5-YL}AMINO)-5-METHYLPYRROLO[2,1-F][1,2,4]TRIAZIN-6-YL]CARBAMATE
- (4-((1-(3-fluorophenyl)methyl)-1H-indazol-5-ylamino)-5-methylpyrrolo(2,1-f)(1,2,4)triazin-6-yl)carbamic acid 3-morpholinylmethyl ester
- (S)-Morpholin-3-ylmethyl (4-((1-(3-fluorobenzyl)-1H-indazol-5-yl)amino)-5-methylpyrrolo[2,1-f][1,2,4
- (S)-morpholin-3-ylmethyl-4-(1-(3-fluorobenzyl)-1H-indazol-5-ylamino)-5-methylpyrrolo[1,2-f][1,2,4]triazin-6-ylcarbamate
- [(3S)-Morpholin-3-yl]methyl [4-({1-[(3-fluorophenyl)methyl]-1H-indazol-5-yl}amino)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]carbamate
- [(3S)-morpholin-3-yl]methyl N-[4-({1-[(3-fluorophenyl)methyl]-1H-indazol-5-yl}amino)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]carbamate
- [4-[[1-(3-Fluorobenzyl)-1H-indazole-5-yl]amino]-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-yl]carbamic acid [(3S)-morpholine-3-yl]methyl ester
- [4-[[1-(3-fluorophenyl)methyl]-1H-indazol-5-ylamino]-5-methyl-pyrrolo[2,1-f][1,2,4]triazin-6-yl]-carbamic acid
- 86448-91-1
- CARBAMIC ACID, [4-[[1-[(3-FLUOROPHENYL)METHYL]-1H-INDAZOL-5-YL]AMINO]-5-METHYLPYRROLO[2,1-F][1,2,4]TRIAZIN-6-YL]-, (3S)-3-MORPHOLINYLMETHYL ESTER
- N-[4-[[1-[(3-Fluorophenyl)methyl]-1H-indazol-5-yl]amino]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]carbamic Acid (3S)-3-Morpholinylmethyl Ester